| Deal Description | New England Nuclear Corporation used the net proceeds of this transaction to repay short-term debt, the balance of which will be added to the general funds of the company and invested in demand deposits, commercial paper, government or municipal obligations, or certificates of deposit. Funds will also be applied to operational expansion in the development, production, and marketing of research products and services, radioactive pharmaceuticals, and other medical diagnostic products. |
|---|
